C2N JMK, Inc.

Biotechnology company · St. Louis, Missouri, United States

C2N JMK, Inc. is a biotechnology company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

C2N JMK at a glance

Typebiotechnology company

HeadquartersSt. Louis, Missouri, United States

Earliest incorporation on record2025

SEC CIK2079558

What does C2N JMK do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $10 million sold (2025).

Frequently asked questions about C2N JMK

Where is C2N JMK headquartered?

C2N JMK, Inc. is headquartered in St. Louis, Missouri, United States.

What does C2N JMK do?

C2N JMK, Inc. is a biotechnology company.

When was C2N JMK founded?

The earliest incorporation on record for C2N JMK, Inc. is in 2025, according to public company registers.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences